Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

Background State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV patients based on four key indicators. Methods Four indicators of health care were assessed: Co...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases Vol. 12; no. 1; p. 229
Main Authors: Podlekareva, Daria N, Reekie, Joanne, Mocroft, Amanda, Losso, Marcelo, Rakhmanova, Aza G, Bakowska, Elzbieta, Karpov, Igor A, Lazarus, Jeffrey V, Gatell, Jose, Lundgren, Jens D, Kirk, Ole
Format: Journal Article
Language:English
Published: London BioMed Central 25.09.2012
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
HIV
RNA
ISSN:1471-2334, 1471-2334
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV patients based on four key indicators. Methods Four indicators of health care were assessed: Compliance with current guidelines on initiation of: 1) combination antiretroviral therapy (cART); 2) chemoprophylaxis; 3) frequency of laboratory monitoring; and 4) virological response to cART (proportion of patients with HIV-RNA < 500copies/ml for >90% of time on cART). Results 7097 EuroSIDA patients were included from Northern (n = 923), Southern (n = 1059), West Central (n = 1290) East Central (n = 1366), Eastern (n = 1964) Europe, and Argentina (n = 495). Patients in Eastern Europe with a CD4 < 200cells/mm 3 were less likely to initiate cART and Pneumocystis jiroveci -chemoprophylaxis compared to patients from all other regions, and less frequently had a laboratory assessment of their disease status. The proportion of patients with virological response was highest in Northern, 89% vs. 84%, 78%, 78%, 61%, 55% in West Central, Southern, East Central Europe, Argentina and Eastern Europe, respectively (p < 0.0001). Compared to Northern, patients from other regions had significantly lower odds of virological response; the difference was most pronounced for Eastern Europe and Argentina (adjusted OR 0.16 [95%CI 0.11-0.23, p < 0.0001]; 0.20[0.14-0.28, p < 0.0001] respectively). Conclusions This assessment of HIV health care utilization revealed pronounced regional differences in adherence to guidelines and can help to identify gaps and direct target interventions. It may serve as a tool for the assessment and benchmarking of the clinical management of HIV patients in any setting worldwide.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1471-2334
1471-2334
DOI:10.1186/1471-2334-12-229